PXS-5382

N/A

Report date: 2026/01/16 14:42:33
NME

Base Information

Drug NamePXS-5382
Drug Alias NamePXS-5382PXS-5382ASNT-5382
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysyl oxidase homolog 2 inhibitors
TargetsLysyl oxidase homolog 2
Therapy Area/IndicationsRenal fibrosisIdiopathic Pulmonary FibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSyntara Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyntara Ltd
Active IndicationsN/A
Inactive IndicationsRenal fibrosisIdiopathic Pulmonary FibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A